Exact Sciences is now Abbott, bringing our leading portfolio of cancer screening and diagnostics tests to the most diversified company in health. Our solutions help patients and healthcare providers make timely, informed decisions before, during and after a cancer diagnosis. Our growing product line includes well-established brands such as Cologuard and Oncotype DX, along with innovative solutions like the Cancerguard test for multi-cancer early detection and the Oncodetect test for molecular residual disease and recurrence monitoring. We continue to invest in a robust pipeline of advanced diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com.